[The efficacy of nicardipine in treating arterial hypertension in elderly patients. A multicenter outpatient study]. / Eficacia de la nicardipina en el tratamiento de la hipertensión arterial en pacientes ancianos. Estudio multicéntrico en régimen de ambulatorio.

In this open study, 210 patients from both sexes, age above 60 years and diagnosis of AHT, were included. All patients were treated, following the washing-out phase, with a calcium antagonist dihydropyridine: nicardipine, at a doses of 60 mg/day for 12 weeks. A significant reduction in SAP (from 168.97 to 152.25 mm Hg.) and DAP (from 98.17 to 87.63 mm Hg.) was observed, without modifications in the cardiac rate. In addition, a low incidence of adverse effects and a high biological tolerance of the drug has been demonstrated during the whole study.